Placebo use and outcome quality: a protocol for systematic review and meta-analysis

Background: The Pharmaceutical industry sponsorship, research outcome and quality has been already evaluated for clinical trials in order to analyze if this kind of sponsorship affects the results of clinical trials. In this sense, this study has the aim to investigate whether placebo use allows p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Piuvezam, Grasiela, Silva, Juliana Carvalho Rocha Alves da, Azevedo, Kesley Pablo Morais de, Farinasso, Cecília Menezes, Silva, Dayde Lane Mendonça da, Stefani, Cristine, Figueiredo, Ana Cláudia Morais Godoy, Souza, Patrícia Medeiros de, Capucho, Helaine Carneiro
Outros Autores: https://orcid.org/0000-0002-2343-7251
Formato: article
Idioma:English
Publicado em: Medicine
Assuntos:
Endereço do item:https://repositorio.ufrn.br/handle/123456789/55329
http://dx.doi.org/10.1097/md.0000000000022915
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
id ri-123456789-55329
record_format dspace
spelling ri-123456789-553292023-11-14T19:09:15Z Placebo use and outcome quality: a protocol for systematic review and meta-analysis Piuvezam, Grasiela Silva, Juliana Carvalho Rocha Alves da Azevedo, Kesley Pablo Morais de Farinasso, Cecília Menezes Silva, Dayde Lane Mendonça da Stefani, Cristine Figueiredo, Ana Cláudia Morais Godoy Souza, Patrícia Medeiros de Capucho, Helaine Carneiro https://orcid.org/0000-0002-2343-7251 clinical trials new drugs new pharmaceutical products placebo systematic review Background: The Pharmaceutical industry sponsorship, research outcome and quality has been already evaluated for clinical trials in order to analyze if this kind of sponsorship affects the results of clinical trials. In this sense, this study has the aim to investigate whether placebo use allows positive outcomes regarding efficacy and safety compared to synthetic medicines. Methods: We designed and registered a study protocol for a systematic review for methodology data. We will only randomized clinical trials that use placebo as comparator. The main outcome will be the evaluation of placebo use regarding the tendency for positive results (efficacy and security) when comparing to synthetic medicines. PubMed, Cochrane, LILACS (BVS), Web of Science, Scopus, and Excerpta Medica dataBASE (EMBASE) databases will be searched. Gray literature will be identified through the databases Proquest (Dissertation and Theses), OpenGrey and Google Scholar. Two review authors will independently assess trial quality and will extract data in accordance with standard Cochrane methodology. If necessary, we will also contact authors for additional information. The Cochrane Collaboration’s risk of bias tool will be used. If feasible, it means homogenous data, we will conduct random effects meta-analysis. Subgroup analyses will be conducted for different justifications for placebo use and for studies sponsored/not sponsored by the pharmaceutical industry. Results: Our present findings will indicate the effects of placebo use as comparator regarding efficacy and safety of the oral synthetic medicines. Discussion: This systematic review will identify, summarize, and analyze if there is a trend for positive efficacy and safety results for synthetic medicines in clinical trials when compared with placebo and if the justification for placebo use is considered ethically acceptable. Systematic review registration: PROSPERO CRD42018110829 Abbreviation: RCTs = randomized controlled clinical trials 2023-11-14T19:08:46Z 2023-11-14T19:08:46Z 2020 article PIUVEZAM, Grasiela; SILVA, Juliana C. R. Alves da; AZEVEDO, Kesley Pablo Morais de; FARINASSO, Cecília Menezes; SILVA, Dayde Lane Mendonça da; STEFANI, Cristine; FIGUEIREDO, Ana Cláudia Morais Godoy; SOUZA, Patrícia Medeiros de; CAPUCHO, Helaine Carneiro. Placebo use and outcome quality. Medicine, [S.l.], v. 99, n. 44, p. 22915, 30 out. 2020. Ovid Technologies (Wolters Kluwer Health). DOI http://dx.doi.org/10.1097/md.0000000000022915. Disponível em: https://journals.lww.com/md-journal/fulltext/2020/10300/placebo_use_and_outcome_quality__a_protocol_for.54.aspx. Acesso em: 9 nov. 2023. https://repositorio.ufrn.br/handle/123456789/55329 http://dx.doi.org/10.1097/md.0000000000022915 en https://creativecommons.org/licenses/by/4.0/deed.pt-br application/pdf Medicine
institution Repositório Institucional
collection RI - UFRN
language English
topic clinical trials
new drugs
new pharmaceutical products
placebo
systematic review
spellingShingle clinical trials
new drugs
new pharmaceutical products
placebo
systematic review
Piuvezam, Grasiela
Silva, Juliana Carvalho Rocha Alves da
Azevedo, Kesley Pablo Morais de
Farinasso, Cecília Menezes
Silva, Dayde Lane Mendonça da
Stefani, Cristine
Figueiredo, Ana Cláudia Morais Godoy
Souza, Patrícia Medeiros de
Capucho, Helaine Carneiro
Placebo use and outcome quality: a protocol for systematic review and meta-analysis
description Background: The Pharmaceutical industry sponsorship, research outcome and quality has been already evaluated for clinical trials in order to analyze if this kind of sponsorship affects the results of clinical trials. In this sense, this study has the aim to investigate whether placebo use allows positive outcomes regarding efficacy and safety compared to synthetic medicines. Methods: We designed and registered a study protocol for a systematic review for methodology data. We will only randomized clinical trials that use placebo as comparator. The main outcome will be the evaluation of placebo use regarding the tendency for positive results (efficacy and security) when comparing to synthetic medicines. PubMed, Cochrane, LILACS (BVS), Web of Science, Scopus, and Excerpta Medica dataBASE (EMBASE) databases will be searched. Gray literature will be identified through the databases Proquest (Dissertation and Theses), OpenGrey and Google Scholar. Two review authors will independently assess trial quality and will extract data in accordance with standard Cochrane methodology. If necessary, we will also contact authors for additional information. The Cochrane Collaboration’s risk of bias tool will be used. If feasible, it means homogenous data, we will conduct random effects meta-analysis. Subgroup analyses will be conducted for different justifications for placebo use and for studies sponsored/not sponsored by the pharmaceutical industry. Results: Our present findings will indicate the effects of placebo use as comparator regarding efficacy and safety of the oral synthetic medicines. Discussion: This systematic review will identify, summarize, and analyze if there is a trend for positive efficacy and safety results for synthetic medicines in clinical trials when compared with placebo and if the justification for placebo use is considered ethically acceptable. Systematic review registration: PROSPERO CRD42018110829 Abbreviation: RCTs = randomized controlled clinical trials
author2 https://orcid.org/0000-0002-2343-7251
author_facet https://orcid.org/0000-0002-2343-7251
Piuvezam, Grasiela
Silva, Juliana Carvalho Rocha Alves da
Azevedo, Kesley Pablo Morais de
Farinasso, Cecília Menezes
Silva, Dayde Lane Mendonça da
Stefani, Cristine
Figueiredo, Ana Cláudia Morais Godoy
Souza, Patrícia Medeiros de
Capucho, Helaine Carneiro
format article
author Piuvezam, Grasiela
Silva, Juliana Carvalho Rocha Alves da
Azevedo, Kesley Pablo Morais de
Farinasso, Cecília Menezes
Silva, Dayde Lane Mendonça da
Stefani, Cristine
Figueiredo, Ana Cláudia Morais Godoy
Souza, Patrícia Medeiros de
Capucho, Helaine Carneiro
author_sort Piuvezam, Grasiela
title Placebo use and outcome quality: a protocol for systematic review and meta-analysis
title_short Placebo use and outcome quality: a protocol for systematic review and meta-analysis
title_full Placebo use and outcome quality: a protocol for systematic review and meta-analysis
title_fullStr Placebo use and outcome quality: a protocol for systematic review and meta-analysis
title_full_unstemmed Placebo use and outcome quality: a protocol for systematic review and meta-analysis
title_sort placebo use and outcome quality: a protocol for systematic review and meta-analysis
publisher Medicine
publishDate 2023
url https://repositorio.ufrn.br/handle/123456789/55329
http://dx.doi.org/10.1097/md.0000000000022915
work_keys_str_mv AT piuvezamgrasiela placebouseandoutcomequalityaprotocolforsystematicreviewandmetaanalysis
AT silvajulianacarvalhorochaalvesda placebouseandoutcomequalityaprotocolforsystematicreviewandmetaanalysis
AT azevedokesleypablomoraisde placebouseandoutcomequalityaprotocolforsystematicreviewandmetaanalysis
AT farinassoceciliamenezes placebouseandoutcomequalityaprotocolforsystematicreviewandmetaanalysis
AT silvadaydelanemendoncada placebouseandoutcomequalityaprotocolforsystematicreviewandmetaanalysis
AT stefanicristine placebouseandoutcomequalityaprotocolforsystematicreviewandmetaanalysis
AT figueiredoanaclaudiamoraisgodoy placebouseandoutcomequalityaprotocolforsystematicreviewandmetaanalysis
AT souzapatriciamedeirosde placebouseandoutcomequalityaprotocolforsystematicreviewandmetaanalysis
AT capuchohelainecarneiro placebouseandoutcomequalityaprotocolforsystematicreviewandmetaanalysis
_version_ 1784351480890785792